Community Research and Development Information Service - CORDIS

Abstract

This is the report of the forty-fifth of a series of workshops organised by the European Centre for the Validation of Alternative Methods (ECVAM). ECVAM's main goal, as defined in 1993 by its Scientific Advisory Committee, is to promote the scientific and regulatory acceptance of alternative methods which are of importance to the biosciences and which reduce, refine or replace the use of laboratory animals. One of the first priorities set by ECVAM was the implementation of procedures that would enable it to become well informed about the state-of-the-art of nonanimal test development and validation, and the potential for the possible incorporation of alternative tests into regulatory procedures. It was decided that this would be best achieved by the organisation of ECVAM workshops on specific topics, at which small groups of invited experts would review the current status of in vitro tests and their potential uses, and make recommendations about the best ways forward. In addition, other topics relevant to the Three Rs concept of alternatives to animal experiments have been considered in several ECVAM workshops.

The full text of this report is available online at: http://altweb.jhsph.edu/publications/ECVAM/ecvam45.htm

Additional information

Authors: PFALLER W, Institute of Physiology, University of Innsbruck (AT);BALLS M, European Commission, Joint Research Centre, Institute for Health & Consumer Protection, ECVAM, Ispra (IT);COECKE S, European Commission, Joint Research Centre, Institute for Health & Consumer Protection, ECVAM, Ispra (IT);PRIETO P, European Commission, Joint Research Centre, Institute for Health & Consumer Protection, ECVAM, Ispra (IT);SLADOWSKI D, European Commission, Joint Research Centre, Institute for Health & Consumer Protection, ECVAM, Ispra (IT);CLOTHIER R, School of Biomedical Sciences, University of Nottingham (GB);DIERICKX P, Institute of Public Health, Laboratory of Biochemical Toxicology, Brussels (BE);ECKWALL B, Pavals När, Stanga (SE);HANLEY B A, CSL Food Science Laboratory, Colney, Norwich (GB);HARTUNG T, Department of Biochemical Pharmacology, University of Konstanz (DE);WENDEL A, Department of Biochemical Pharmacology, University of Konstanz (DE);RYAN M P, Department of Pharmacology, University College, Dublin (IE);SCHMUCK G, Bayer AG, Business Group Pharma, Ph-PD Toxicology, Wuppertal (DE);VERICAT J-A, Sanofi-Synthelabo Recherche, Porcheville (FR);WOLF A, Novartis Pharma AG, Toxicology/Pathology, Basel (CH);ZIMMER J, Institute of Medical Biology, University of Odense (DK)
Bibliographic Reference: A report published by FRAME for EVCAM (reprinted with minor amendments from ATLA 29: 393-426)
Record Number: 200214697 / Last updated on: 2002-05-15
Category: PUBLICATION
Original language: en
Available languages: en